Alzheimer’s Disease

1 Genetics of Alzheimer’s Disease and Related Disorders.- 2 Neuropathology of Alzheimer’s Disease.- 3 Oxidative Stress in the Development of Alzheimer’s Disease and Other Dementias.- 4 Metabolism and Alzheimer’s Disease.- 5 Alzheimer’s Disease: Epidemiological and Statistical Data.- 6 The Economic Burden of Alzheimer’s Disease and Dementia.- 7 Potential and Established Risk Factors for Alzheimer’s Disease.- 8 Medical Diagnosis and Workup of Alzheimer’s Disease.- 9 Neuroimaging Techniques: CT, MRI, SPECT, PET.- 10 Biological Markers in Alzheimer’s Disease.- 11 The Neuropsychology of Alzheimer’s Disease.- 12 Vascular Cognitive Impairment in Clinical Practice.- 13 Lewy Body Disease.- 14 Frontotemporal Lobe Dementia.- 15 Mild Forgetfulness: Distinguishing Early AD from Normal Aging.- 16 Mild Cognitive Impairment: What the Physician Should Know.- 17 Diagnosis of Predementia AD in a Clinical Setting.- 18 Loss of Olfactory Function in Patients With Alzheimer’s Disease.- 19 Treatment of Alzheimer’s Disease: Basic Considerations.- 20 Donepezil in Treatment of AD.- 21 Rivastigmine for Treatment of AD.- 22 Galantamine in Treatment of AD.- 23 Memantine in Treatment of AD.- 24 Alternative Treatment Options.- 25 Pain and Palliative Care in Late-Stage Dementia Patients.- 26 Cardiological Issues in Late-Stage Alzheimer’s Disease: A Clinician’s Approach.- 27 Neuroprotection and Neurodegenerative Disease.- 28 Neurotrophic Factors for Prevention of Alzheimer’s Disease.- 29 Statins in Prevention and Treatment of Alzheimer’s Disease.- 30 Potential Role of Androgens and Androgen Receptors in Alzheimer’s Disease.- 31 Role of Nutrition in Prevention or Delay of Alzheimer’s Disease.- 32 Impact of Physical Activity on Prevention of Alzheimer’s Disease.- 33Stem Cell Therapy for Alzheimer’s Disease.- 34 Secretases as Potential Targets for Treatment of Alzheimer’s Disease.- 35 AMPA Potentiation as a Treatment Option for Alzheimer’s Disease.- 36 Glycosaminoglycans as Potential Future Treatment of Alzheimer’s Disease.- 37 Implications of Research for Management of AD.- 38 Rating Scales and Outcome Variables Used in Clinical Trials.- 39 Gender Differences in Behavior of AD Patients.- 40 Management of Emotional and Behavioral Symptoms in AD.- 41 Assessment and Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease.- 42 Neuropsychiatric Symptoms in African American Dementia Patients.- 43 Resource Utilization by African American Dementia Patients.- 44 Apathy in Alzheimer’s Disease: Relationship to Executive Function.- 45 Are Alzheimer’s Patients Aware of Their Deficits?.- 46 Diagnostic Family Conference in AD: Issues and Recommendations.- 47 Care, Caregiver Issues, and Communication With the Demented Patient.- 48 Dental Care of AD Patients.- 49 Long-Term Medical Care Issues.- 50 Loneliness and Depression in Caregivers.- 51 Frequently Asked Questions About Alzheimer’s Disease.